FROM Jesse Lawler
Smart Drugs: The Quest for Getting an Edge Let's face it, who doesn't want to be sharper, more alert, and able to ace anything you want to do without having to get much sleep? Now, in addition to Ritalin and Adderall, there's a new crop of over-the-counter drugs aimed at enhancing brain function, including Provigil and Modafinil. Originally a narcolepsy drug Modafanil – or Moda -- is easy to obtain on college campuses now. Entrepreneurs, video gamers, office workers and musicians are taking it to give them an edge in a competitive world. But is it safe? Is this the beginning of a medicalized level doping of our minds? Are smart drugs miracle pills, pathways to addiction or just plain cheating?
Replacing Obamacare: Now you see it… now you don’t As the Senate deliberates replacing Obmacare, health coverage for millions of people is at stake. There've been no public hearings, and a draft measure won't be made public. Is the House version so unpopular that that Senate is hiding a version that looks much the same?
Is the threat from Russia missing from the Russia meddling probe? There's much being made about the Trump administration's possible ties with Russia. But the bottom line is Russia's effort to influence American democracy. Do the President and his aides care enough to take action before voters go back to the polls?
Will the Senate write a healthcare bill in secret? While Democrats and Republicans argue White House relations with Russia, another question is being decided behind closed doors: who gets help buying health insurance and who doesn't? We hear how the pros and cons are being shrouded in secrecy.
Who's to blame for the opioid crisis? Some of the lawyers who took on Big Tobacco are now going after Big Pharma. It’s all about the deadly epidemic of opioid use. Are the drug companies to blame? What about the users? Later, on today’s Talking Point: making sense of Britain’s upset election.